Research is being conducted on the use of [68Ga]Ga-FAPI-46 as an imaging biomarker for tumors that are positive for fibroblast activation protein (FAP). The compound is being explored for its potential in detecting various types of cancer, including glioblastoma and mucoepidermoid carcinoma. Studies are investigating its effectiveness in imaging and guiding treatment, with possible applications in precision medicine and radionuclide therapy.